NEWRON PHARMACEUT. EO-20 (NP5) — Cash Flow Quality Index
NEWRON PHARMACEUT. EO-20 (NP5) has a Cash Flow Quality Index of -1.11x as of December 2024. Operating cash flow of €-17.61 Million is below net income of €15.84 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore NEWRON PHARMACEUT. EO-20 balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
NEWRON PHARMACEUT. EO-20 Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for NEWRON PHARMACEUT. EO-20 across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check NP5 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for NEWRON PHARMACEUT. EO-20 (2024–2024)
Year-by-year earnings quality comparison for NEWRON PHARMACEUT. EO-20. For live market cap and the full company financial profile, see NEWRON PHARMACEUT. EO-20 (NP5) total market value.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.11x | €-17.61 Million | €15.84 Million | — |